<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04045158</url>
  </required_header>
  <id_info>
    <org_study_id>DIAPH-NMD</org_study_id>
    <nct_id>NCT04045158</nct_id>
  </id_info>
  <brief_title>Diaphragm Ultrasound in Neuromuscular Disorders</brief_title>
  <official_title>Diaphragm Ultrasound in Neuromuscular Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Muscular dystrophies are neurologic disease with higher morbidity and mortality. Cardiac
      function and respiratory muscles can be affected, in addition with skeletal muscle deficiency
      . Lung function is classically assessed with functionnal pulmonary tests (FPT) . Ultrasound
      recently emerged as a non-invasive tool to assess diaphragm function.

      The aims of the study are:

        -  to provide the spectrum of diaphragm ultrasound in patients with muscular dystrophies

        -  to assess the correlation between diaphragm ultrasound and FPT

        -  to assess the correlation between diaphragm ultrasound and cardiac function
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 15, 2019</start_date>
  <completion_date type="Anticipated">May 10, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 28, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>diaphragm ultrasound motion</measure>
    <time_frame>1 year</time_frame>
    <description>using echography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation between diaphragm motion (mm) and forced vital capacity(ml)</measure>
    <time_frame>1 year</time_frame>
    <description>using echography and FPT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation between diaphragm motion (mm) and inspiratory capacity (ml)</measure>
    <time_frame>1 year</time_frame>
    <description>using echography and FPT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diaphragm thickness (mm)</measure>
    <time_frame>1 year</time_frame>
    <description>using echography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation between diaphargm thickness and maximal inspiratory pressure (cmH20)</measure>
    <time_frame>1 year</time_frame>
    <description>using echography and FPT</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Muscular Dystrophies</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with neuromuscular diseases admitted for a cardio-respiratory function evaluation
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Duchenne muscular dystrophy,

          -  Becker muscular dystrophy,

          -  LGMD,

          -  myotonic dystrophy type 1 and type 2,

          -  metabolic myopathy,

          -  mitochondrial myopathy,

          -  FSHD1 and 2,

          -  myasthenia

        Exclusion Criteria:

          -  history of cardiac surgery

          -  history of thoracic surgery

          -  brain traumatism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Hopital Raymond Poincare</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 22, 2019</study_first_submitted>
  <study_first_submitted_qc>August 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2019</study_first_posted>
  <last_update_submitted>August 2, 2019</last_update_submitted>
  <last_update_submitted_qc>August 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre d'Investigation Clinique et Technologique 805</investigator_affiliation>
    <investigator_full_name>Abdallah FAYSSOIL</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>diaphragm</keyword>
  <keyword>ultrasound</keyword>
  <keyword>echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

